{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "27021784", "DateCompleted": {"Year": "2016", "Month": "12", "Day": "13"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "21"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2016", "Month": "03", "Day": "29"}], "ELocationID": ["10.1039/c5pp00467e"], "Journal": {"ISSN": "1474-9092", "JournalIssue": {"Volume": "15", "Issue": "4", "PubDate": {"Year": "2016", "Month": "Apr"}}, "Title": "Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology", "ISOAbbreviation": "Photochem Photobiol Sci"}, "ArticleTitle": "Topical formulation containing hesperidin methyl chalcone inhibits skin oxidative stress and inflammation induced by ultraviolet B irradiation.", "Pagination": {"StartPage": "554", "EndPage": "563", "MedlinePgn": "554-63"}, "Abstract": {"AbstractText": ["Skin exposure to ultraviolet B (UVB) irradiation has increased significantly in recent years due to ozone depletion, and it represents the main cause of many skin diseases. Hesperidin methyl chalcone (HMC) is a compound used to treat vascular diseases that has demonstrated anti-inflammatory activities in pre-clinical studies. Herein, we tested the antioxidant activity of HMC in cell free systems and the in vivo effects of a stable topical formulation containing HMC in a mouse model of skin oxidative stress and inflammation induced by UVB irradiation. HMC presented ferric reducing power, neutralized 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and hydroxyl free radicals, and inhibited lipid peroxidation. In hairless mice, a topical formulation containing HMC inhibited UVB irradiation-induced skin edema, depletion of antioxidant capacity (ferric and ABTS reducing abilities and catalase activity), lipid peroxidation, superoxide anion production and mRNA expression of gp91phox (nicotinamide adenine dinucleotide phosphate [NADPH] oxidase 2 sub-unity). In addition, HMC inhibited UVB irradiation-induced depletion of reduced glutathione levels by maintaining glutathione peroxidase-1 and glutathione reductase mRNA expression, prevented down-regulation of nuclear factor erythroid 2-related factor 2 (Nrf2) mRNA expression and increased heme oxygenase-1 mRNA expression. Finally, we demonstrated that topical application of the formulation containing HMC inhibited cytokine (TNF-\u03b1, IL-1\u03b2, IL-6, and IL-10) production induced by UVB irradiation. Therefore, this topical formulation containing HMC is a promising new therapeutic approach to protecting the skin from the deleterious effects of UVB irradiation."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Ci\u00eancias Farmac\u00eauticas, Universidade Estadual de Londrina, Avenida Robert Koch, 60, Hospital Universit\u00e1rio, 86039-440 Londrina, Paran\u00e1, Brazil. rubiacasa@yahoo.com.br."}], "LastName": "Martinez", "ForeName": "Renata M", "Initials": "RM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Pinho-Ribeiro", "ForeName": "Felipe A", "Initials": "FA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Steffen", "ForeName": "Vinicius S", "Initials": "VS"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Caviglione", "ForeName": "Carla V", "Initials": "CV"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Pala", "ForeName": "Danilo", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Baracat", "ForeName": "Marcela M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Georgetti", "ForeName": "Sandra R", "Initials": "SR"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Verri", "ForeName": "Waldiceu A", "Initials": "WA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Casagrande", "ForeName": "Rubia", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Photochem Photobiol Sci", "NlmUniqueID": "101124451", "ISSNLinking": "1474-905X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Chalcones"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Glycoproteins"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-E2-Related Factor 2"}, {"RegistryNumber": "0", "NameOfSubstance": "Nfe2l2 protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "11062-77-4", "NameOfSubstance": "Superoxides"}, {"RegistryNumber": "4T2GVA922X", "NameOfSubstance": "hesperidin methylchalcone"}, {"RegistryNumber": "E750O06Y6O", "NameOfSubstance": "Hesperidin"}, {"RegistryNumber": "EC 1.14.14.18", "NameOfSubstance": "Heme Oxygenase-1"}, {"RegistryNumber": "EC 1.6.3.-", "NameOfSubstance": "Cybb protein, mouse"}, {"RegistryNumber": "EC 1.6.3.-", "NameOfSubstance": "NADPH Oxidase 2"}, {"RegistryNumber": "EC 1.6.3.-", "NameOfSubstance": "NADPH Oxidases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Topical"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Chalcones"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Cytokines"}, {"QualifierName": ["genetics"], "DescriptorName": "Heme Oxygenase-1"}, {"QualifierName": ["administration & dosage", "analogs & derivatives", "pharmacology"], "DescriptorName": "Hesperidin"}, {"QualifierName": ["metabolism", "prevention & control"], "DescriptorName": "Inflammation"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Membrane Glycoproteins"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Hairless"}, {"QualifierName": [], "DescriptorName": "NADPH Oxidase 2"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "NADPH Oxidases"}, {"QualifierName": ["genetics"], "DescriptorName": "NF-E2-Related Factor 2"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["genetics"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Skin"}, {"QualifierName": ["metabolism"], "DescriptorName": "Superoxides"}, {"QualifierName": [], "DescriptorName": "Ultraviolet Rays"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "3", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "3", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27021784", "10.1039/c5pp00467e"]}}], "PubmedBookArticle": []}